CPChristoph Pautke

Christoph Pautke

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christoph Pautke has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Controversial Aspects of Diagnostics and Therapy of Idiopathic Condylar Resorption: An Analysis of Evidence- and Consensus-Based Recommendations Based on an Interdisciplinary Guideline Project

    by Merle Riechmann, Christopher Schmidt, M. Oliver Ahlers, Ima Feurer, Johannes Kleinheinz, Andreas Kolk, Christoph Pautke, Andreas Schön, Marcus Teschke, Astrid Toferer, et al.

    Idiopathic condylar resorption (ICR), though a rare event, is associated with severe detrimental sequelae for the patient. To date, the etiology remains unknown, and treatment strategies are highly controversial. Therefore, the aim of this study is to present an analysis of the consensus- and evidence-based approach to ICR by a German interdisciplinary guideline project of the AWMF (Association of the Scientific Medical Societies in Germany). Following a systematic literature search, including 56 (out of an initial 97) publications, with a predominantly low level of evidence (LoE), two independent working groups (oral and maxillofacial surgery and interdisciplinary, respectively) voted on a draft comprising 25 recommendations in a standardized anonymized and blinded Delphi procedure. While the results of the votes were relatively homogeneous, the interdisciplinary phase required a significantly higher number of rounds (p < 0.001). Most of the controversial recommendations were related to initial imaging (with consensus on CT/CBCT as the current diagnostic standard for imaging), pharmacotherapy (no recommendation due to lack of evidence), discopexy (no recommendation possible due to low LoE) and timing of orthognathic surgery (with consensus on two-staged procedures after invasive TMJ surgery, except for single-stage procedures if combined with total joint reconstruction). Overall, the Delphi procedure resulted in an interdisciplinary guideline offering the best possible evidence- and consensus-based expertise to date in the diagnosis and treatment of ICR.


  • Open Access

    Controversial Aspects of Diagnostics and Therapy of Arthritis of the Temporomandibular Joint in Rheumatoid and Juvenile Idiopathic Arthritis—An Analysis of Evidence- and Consensus-Based Recommendations Based on an Interdisciplinary Guideline Project

    by Christopher Schmidt, Rudolf Reich, Bernd Koos, Taila Ertel, Marcus Oliver Ahlers, Martin Arbogast, Ima Feurer, Mario Habermann-Krebs, Tim Hilgenfeld, Christian Hirsch, et al.

    Introduction: Due to potentially severe sequelae (impaired growth, condylar resorption, and ankylosis) early diagnosis of chronic rheumatic arthritis of the temporomandibular joint (TMJ) and timely onset of therapy are essential. Aim: Owing to very limited evidence the aim of the study was to identify and discuss controversial topics in the guideline development to promote further focused research. Methods: Through a systematic literature search, 394 out of 3771 publications were included in a German interdisciplinary guideline draft. Two workgroups (1: oral and maxillofacial surgery, 2: interdisciplinary) voted on 77 recommendations/statements, in 2 independent anonymized and blinded consensus phases (Delphi process). Results: The voting results were relatively homogenous, except for a greater proportion of abstentions amongst the interdisciplinary group (p < 0.001). Eighty-four percent of recommendations/statements were approved in the first round, 89% with strong consensus. Fourteen recommendations/statements (18.2%) required a prolonged consensus phase and further discussion. Discussion: Contrast-enhanced MRI was confirmed as the method of choice for the diagnosis of TMJ arthritis. Intraarticular corticosteroid injection is to be limited to therapy-refractory cases and single injection only. In adults, alloplastic joint replacement is preferable to autologous replacement. In children/adolescents, autologous reconstruction may be performed lacking viable alternatives. Alloplastic options are currently still considered experimental.


  • Top Cited Papers
    Open Access

    Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases

    by Sven Otto, Christoph Pautke, Tim Van Den Wyngaert, Daniela Niepel, Morten Schiødt


  • Open Access

    A dental myth bites the dust – no observable relation between the incidence of dental abscess and the weather and lunar phase: an ecological study

    by Oliver Ristow, Steffen Koerdt, Ruben Stelzner, Matthias Stelzner, Christoph Johannes, Melanie Ristow, Bettina Hohlweg-Majert, Christoph Pautke

    Anecdotal reports assert a relationship between weather and lunar activity and the odontogenic abscess (OA) incidence, but this relationship has not been validated. Therefore, the present study investigated the relationship between oral pain caused by OA and a variety of meteorological parameters and cyclic lunar activity. The records of all dental emergency patients treated at the AllDent Zahnzentrum Emergency Unit in Munich, Germany during 2012 were retrospectively reviewed. Patients with oral pain who were diagnosed with OA and treated surgically (n = 1211) were included in the analysis. The OA incidence was correlated to daily meteorological data, biosynoptic weather analysis, and cyclic lunar activity. There was no seasonal variation in the OA incidence. None of the meteorological parameters, lunar phase, or biosynoptic weather class were significantly correlated with the OA incidence, except the mean barometric pressure, which was weakly correlated (rho = -0.204). The OA incidence showed a decreasing trend as barometric pressure increased (p < 0.001). On multiple linear regression, the barometric pressure accounted for approximately 4% of the OA incidence. There is no evidence supporting a correlation between the incidence of odontogenic abscess and the weather and lunar activities.


  • Bisphosphonate related osteonecrosis of the jaw: A minipig large animal model

    by Christoph Pautke, Kilian Kreutzer, Jochen Weitz, Martina Knödler, Daniela Münzel, Gabriele Wexel, Sven Otto, Alexander Hapfelmeier, Stephen Stürzenbaum, Thomas Tischer


  • Bisphosphonat-assoziierte Kiefernekrosen

    by S. Otto, M. Schieker, C. Pautke

    Stickstoffhaltige Bisphosphonate (BP) werden erfolgreich in der Osteoporose- und der supportiven onkologischen Therapie eingesetzt. Erste Fälle von BP-assoziierten Kiefernekrosen (KN) wurden 2003 in verschiedenen Fallberichten veröffentlicht. Insbesondere unter oraler BP-Therapie bei Osteoporose handelt es sich dabei jedoch um ein sehr seltenes Krankheitsbild. Die Pathogenese der BP-assoziierten KN ist bisher noch nicht vollständig verstanden. Wir glauben, dass letztlich entzündliche Prozesse mit lokal saurem pH-Wert zur Akkumulation von BP im Kieferknochen und lokaler Gewebetoxizität führen. Deshalb reduzieren zahnärztliche Maßnahmen zur Beseitigung von Entzündungsherden signifikant die KN bei onkologischen Patienten unter intravenöser BP-Therapie. Leider gab es bisher keine relevanten Tiermodelle, in denen die Pathogenese und therapeutischen Maßnahmen klinisch relevant getestet werden können. Aktuell haben wir ein Minipig-Modell durch Zahnextraktion und Gabe von i. v.-Zoledronat in der gewichtsadaptierten onkologischen Dosierung etabliert. Mit diesem Modell wird es möglich sein, die Pathogenese von BP- assoziierten KN besser zu verstehen und mögliche Therapieoptionen zu testen. Bisphosphonates have been successfully used for almost 20 years to treat osteoporosis or as supportive therapy of bone metastasis. First cases of bisphosphonate related osteonecrosis of the jaw (BRONJ) were reported to the FDA in 2001 and were published as case reports in 2003. To date there are still contradictory publications on the prevalence of BRONJ in literature. However, ONJ is a very rare disease in oral treatment regimen for osteoporosis. The development of BRONJ has a multi- factorial aetiology and the clinical presentation can vary markedly. Moreover, the precise pathogenesis largely remains elusive. Yet, we believe that local tissue acidosis due to local infections in the jaw bone offers a conclusive pathogenesis model and may prove to be the missing link in bisphosphonate related ONJ. Bone-bound bisphosphonates are released at acidic pH, accumulate in jawbone and lead to local tissue toxicity. This might explain why dental procedures to treat foci of inflammation can significantly reduce BRONJ in patients treated with iv-bisphosphonates in oncologic treatment regimens. Unfortunately, relevant large animal models have not been published yet. Most recently we have established a large animal model to induce BRONJ by tooth-extraction and iv-zoledronate treatment in oncologically relevant doses in minipigs. This model gives evidence that bisphosphonates are causally linked to the onset of BRONJ. Moreover, investigations in large animal models will allow for better understanding of the pathogenesis and will allow for testing of new therapeutic strategies for bisphosphonate related ONJ.


  • Open Access

    Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: A case report

    by Sven Otto, Karl Sotlar, Michael Ehrenfeld, Christoph Pautke

    Osteonecrosis of the jaw is a serious side effect in patients receiving nitrogen-containing bisphosphonates intravenously due to malignant diseases. Albeit far less frequently, osteonecrosis of the jaw has also been reported to occur due to the oral administration of nitrogen-containing bisphosphonates due to osteoporosis. Annual infusions of zoledronic acid have been recommended in order to improve patient compliance, to optimize therapeutic effects and to minimize side effects. To date, osteonecrosis of the jaw has not been linked to the annual administration of bisphosphonates.